Antitubercular properties of thiazolidin-4-ones - A review.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Apr 2021
Historique:
received: 19 10 2020
revised: 27 01 2021
accepted: 01 02 2021
pubmed: 16 2 2021
medline: 27 5 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Thiazolidin-4-one scaffold has great potential for medicinal chemistry and is of interest to scientists in view of wide spectrum of biological activity. This scaffold is often used for designing of small molecules with various biological activity including antituberculosis activity. The presented review is an attempt to gather, analyze and systemize data about antitubercular properties of thiazolidine-4-ones from two last decades. Some of them have promising antitubercular activity which is significantly higher than that of the reference drugs. Among them compounds 82c, 82d and 84 that were active against M. tuberculosis H37Rv strain with MICs in the range of 0.05-0.2 μg/mL and compound 108 exhibited activity with MIC = 0.36 μM. Compounds 115a-115c and 116a-116c were very effective against M. tuberculosis H37Ra with MIC values in the range of 0.031-0.125 μg/mL. Acidomycin was showed activity against seven MDR M. tuberculosis strains with MICs in the range of 0.6-0.62 μM and against two XDR M. tuberculosis strains with MICs 0.096 and 1.2 μM. The structure-activity relationship (SAR) of some groups of compounds, as well as some potential molecular targets were also discussed.

Identifiants

pubmed: 33588179
pii: S0223-5234(21)00115-X
doi: 10.1016/j.ejmech.2021.113266
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Thiazolidines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113266

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Nazar Trotsko (N)

Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4a Chodzki Str., 20-093, Lublin, Poland. Electronic address: nazar.trotsko@umlub.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH